Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3400-3408

  Naldini, Antonella ^a   Filippi, Irene ^a   Miglietta, Diego ^a   Moschetta, Michele ^b   Giavazzi, Raffaella ^b   Carraro, Fabio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Breast cancer; Cell migration; CXCL8; HIF 1 ; IL 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL MOVEMENT; ENZYME INHIBITORS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMIDAZOLES; INTERLEUKIN-1BETA; INTERLEUKIN-8; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PYRIDINES; TRANSPLANTATION, HETEROLOGOUS;

EID: 78649631703     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.044     Document Type: Article

References (34)

1. C. Murdoch, M. Muthana, S.B. Coffelt, and C.E. Lewis The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 2008 618 631
2. C.A. Dinarello The interleukin-1 family: 10 years of discovery FASEB J 8 1994 1314 1325
3. J. Wilson, and F. Balkwill The role of cytokines in the epithelial cancer microenvironment Semin Cancer Biol 12 2002 113 120
4. M.R. Bani, A. Garofalo, E. Scanziani, and R. Giavazzi Effect of interleukin-1-beta on metastasis formation in different tumor systems J Natl Cancer Inst 83 1991 119 123
5. E. Voronov, D.S. Shouval, and Y. Krelin IL-1 is required for tumor invasiveness and angiogenesis Proc Natl Acad Sci U S A 100 2003 2645 2650
6. A. Naldini, D. Leali, and A. Pucci Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes J Immunol 177 2006 4267 4270
7. Y. Saijo, M. Tanaka, and M. Miki Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction J Immunol 169 2002 469 475
8. E.A. Suswam, L.B. Nabors, Y. Huang, X. Yang, and P.H. King IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR Int J Cancer 113 2005 911 919
9. P.J. Maxwell, R. Gallagher, and A. Seaton HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells Oncogene 26 2007 7333 7345
10. E. Charafe-Jauffret, C. Ginestier, and F. Iovino Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature Cancer Res 69 2009 1302 1313
11. Y.J. Jung, J.S. Isaacs, S. Lee, J. Trepel, and L. Neckers IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J 17 2003 2115 2117
12. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
13. A. Naldini, I. Filippi, and C. Ardinghi Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells Eur J Cancer 45 2009 454 460
14. Z. Salah, M. Maoz, and E. Pokroy Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression Mol Cancer Res 5 2007 229 240
15. K. Kasuno, S. Takabuchi, and K. Fukuda Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling J Biol Chem 279 2004 2550 2558
16. R. Buccione, M. Baldassarre, and V. Trapani Glycerophosphoinositols inhibit the ability of tumour cells to invade the extracellular matrix Eur J Cancer 41 2005 470 476
17. A. Mantovani, F. Marchesi, C. Porta, A. Sica, and P. Allavena Inflammation and cancer: breast cancer as a prototype Breast 16 2007 S27 S33
18. R.G. Chirivi, C. Chiodoni, and P. Musiani IL-1alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice Int J Cancer 67 1996 856 863
19. D. Belotti, V. Vergani, and T. Drudis The microtubule-affecting drug paclitaxel has antiangiogenic activity Clin Cancer Res 2 1996 1843 1849
20. J. Vandesompele, P.K. De, and F. Pattyn Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 1 12
21. J.M. Kyriakis, and J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol Rev 81 2001 807 869
22. R. Ramjeesingh, R. Leung, and C.H. Siu Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1 FASEB J 17 2003 1292 1294
23. D. Boraschi, L. Villa, and G. Volpini Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo Eur J Immunol 20 1990 317 321
24. D. Bar, R.N. Apte, E. Voronov, C.A. Dinarello, and S. Cohen A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development FASEB J 18 2004 161 163
25. R.G. Chirivi, A. Garofalo, I.M. Padura, A. Mantovani, and R. Giavazzi Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system Cancer Res 53 1993 5051 5054
26. H. Ichijo From receptors to stress-activated MAP kinases Oncogene 18 1999 6087 6093
27. I. Shin, S. Kim, H. Song, H.R. Kim, and A. Moon H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells J Biol Chem 280 2005 14675 14683
28. S.R. Coughlin, and E. Camerer PARticipation in inflammation J Clin Invest 111 2003 25 27
29. N.E. Tsopanoglou, and M.E. Maragoudakis Role of thrombin in angiogenesis and tumor progression Semin Thromb Hemost 30 2004 63 69
30. Q.D. Nguyen, W.O. De, and E. Bruyneel Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment Oncogene 24 2005 8240 8251
31. N. Asokananthan, P.T. Graham, and J. Fink Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells J Immunol 168 2002 3577 3585
32. D.J. Waugh, and C. Wilson The interleukin-8 pathway in cancer Clin Cancer Res 14 2008 6735 6741
33. J.S. Wolf, Z. Chen, and G. Dong IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas Clin Cancer Res 7 2001 1812 1820
34. D. Melisi, J. Niu, and Z. Chang Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB Mol Cancer Res 7 2009 624 633